Arca
Skip to content

SLC10A2: Ileal sodium/bile acid cotransporter

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Plays a critical role in the sodium-dependent reabsorption of bile acids from the lumen of the small intestine.

  • Drugs that act on it: 5
  • With a US drug page: 3
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
LinerixibatApprovedIleal bile acid transporter inhibitorInhibitor—
MaralixibatApprovedIleal bile acid transporter inhibitorInhibitor—
OdevixibatApprovedIleal bile acid transporter inhibitorInhibitor—
Elobixibat—Ileal bile acid transporter inhibitorInhibitor—
Volixibat—Ileal bile acid transporter inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Bile acid malabsorption, primary, 1
0.67
Cholelithiasis
0.57
Gallstones
0.56
Constipation disorder
0.49
Intrahepatic cholestasis
0.48
Familial intrahepatic cholestasis
0.37
Biliary atresia
0.35
Gout
0.35

Drugs and mechanisms are from ChEMBL CHEMBL2778 (CC BY-SA 3.0). Gene name, function (UniProt Q12908, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.